| Product Code: ETC11877153 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Enteric Disease Testing and Therapeutic Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Enteric Disease Testing and Therapeutic Market - Industry Life Cycle |
3.4 Serbia Enteric Disease Testing and Therapeutic Market - Porter's Five Forces |
3.5 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Testing Type, 2021 & 2031F |
3.6 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.9 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Serbia Enteric Disease Testing and Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about enteric diseases in Serbia |
4.2.2 Growing government initiatives for improving healthcare infrastructure |
4.2.3 Rising prevalence of enteric diseases in the region |
4.3 Market Restraints |
4.3.1 Limited access to advanced testing and therapeutic solutions in remote areas |
4.3.2 High cost associated with enteric disease testing and treatment |
4.3.3 Lack of skilled healthcare professionals for accurate diagnosis and treatment |
5 Serbia Enteric Disease Testing and Therapeutic Market Trends |
6 Serbia Enteric Disease Testing and Therapeutic Market, By Types |
6.1 Serbia Enteric Disease Testing and Therapeutic Market, By Testing Type |
6.1.1 Overview and Analysis |
6.1.2 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Testing Type, 2021 - 2031F |
6.1.3 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Molecular Testing, 2021 - 2031F |
6.1.4 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Stool Culture, 2021 - 2031F |
6.1.5 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Serological Testing, 2021 - 2031F |
6.1.6 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Rapid Testing Kits, 2021 - 2031F |
6.2 Serbia Enteric Disease Testing and Therapeutic Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Gastroenteritis, 2021 - 2031F |
6.2.3 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Cholera, 2021 - 2031F |
6.2.4 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Salmonella Infection, 2021 - 2031F |
6.2.5 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By E. Coli Infection, 2021 - 2031F |
6.3 Serbia Enteric Disease Testing and Therapeutic Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.3.4 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.3.5 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 Serbia Enteric Disease Testing and Therapeutic Market, By Treatment Type |
6.4.1 Overview and Analysis |
6.4.2 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Antiviral Therapy, 2021 - 2031F |
6.4.3 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Antibiotic Therapy, 2021 - 2031F |
6.4.4 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Probiotic Therapy, 2021 - 2031F |
6.4.5 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Vaccine Therapy, 2021 - 2031F |
6.5 Serbia Enteric Disease Testing and Therapeutic Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.5.3 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Specialty Pharmacies, 2021 - 2031F |
6.5.4 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Online Retail, 2021 - 2031F |
6.5.5 Serbia Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
7 Serbia Enteric Disease Testing and Therapeutic Market Import-Export Trade Statistics |
7.1 Serbia Enteric Disease Testing and Therapeutic Market Export to Major Countries |
7.2 Serbia Enteric Disease Testing and Therapeutic Market Imports from Major Countries |
8 Serbia Enteric Disease Testing and Therapeutic Market Key Performance Indicators |
8.1 Percentage increase in the number of healthcare facilities offering enteric disease testing and treatment |
8.2 Rate of adoption of advanced technologies for enteric disease diagnosis and treatment |
8.3 Number of research and development initiatives focused on improving enteric disease testing methods |
9 Serbia Enteric Disease Testing and Therapeutic Market - Opportunity Assessment |
9.1 Serbia Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Testing Type, 2021 & 2031F |
9.2 Serbia Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Serbia Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Serbia Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.5 Serbia Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Serbia Enteric Disease Testing and Therapeutic Market - Competitive Landscape |
10.1 Serbia Enteric Disease Testing and Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Serbia Enteric Disease Testing and Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here